Ultimate Fighting Championship (UFC) Welterweight contender, Michel Prazeres, has been hit with a two-year suspension from mixed martial arts (MMA) after failing two out-of-competition drug tests administered by United States Anti-Doping Agency (USADA).
From the official USADA statement:
Prazeres, 38, tested positive for exogenous boldenone and its metabolite 5β-androst-1-en-17β-ol-3-one as the result of two out-of-competition urine samples he provided on March 9, 2019. Confirmation of the positive test was achieved through additional analysis using the sensitive isotope ratio mass spectrometry (GC/C/IRMS) method, which reported laboratory results consistent with the exogenous origin of boldenone. Boldenone is a non-Specified Substance in the class of Anabolic Agents and is prohibited at all times under the UFC Anti-Doping Policy and UFC Prohibited List.
The samples were collected several weeks after Prazeres lost to Ismail Naurdiev at UFC Fight Night 145 in Prague, Czech Republic, almost a year ago. The loss snapped an eight-fight win streak that dated back to 2015.
Since the suspension is retroactive, Prazeres will be eligible to return in March 2021. That said, his climb up the 170-pound division will be a whole lot tougher once he gets back into the swing of things.
Assuming UFC doesn’t let him go altogether.